Prof Ganapati D Yadav selected for ‘Paryavaran Bhushan' award
Prof Yadav, former Vice Chancellor of the Institute of Chemical Technology (ICT), Mumbai, currently serves as the National Science Chair under the Government of India. He is also a Bhatnagar Fellow, the highest distinction awarded by the Council of Scientific and Industrial Research (CSIR).
The 'Paryavaran Bhushan' award celebrates individuals who have made outstanding contributions to environmental protection.
Prof Yadav's selection underscores his lifelong dedication to green science and his impact on the global push for sustainability.
Prof Yadav is recognised globally for his pioneering work in green hydrogen, circular economy, and carbon dioxide valorisation — key domains driving the global pursuit of net-negative energy transition and sustainable development.
Prof Yadav's research has played a critical role in advancing sustainable energy solutions. With over 150 national and international accolades, awards, fellowships and distinctions, Prof Yadav is one of the most decorated engineering scientists in India.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NDTV
04-08-2025
- NDTV
"Public Interest": Court Stays Scientist's Jail Term In Wife's Suicide Case
Nainital: The Uttarakhand High Court has stayed the conviction and five-year rigorous imprisonment of a vaccine scientist who was found guilty of abetting his wife's suicide. Granting relief to the scientist, Akash Yadav, who has done PhD in biotechnology from IIT Kharagpur, the single bench of Justice Ravindra Maithani said suspending his conviction was in the larger public interest. The court observed that the convict was a scientist actively engaged in vaccine research and development and due to his conviction, he was unable to perform his duties. It also said that the scientist's research holds critical value for the society at large. Yadav was booked under the Dowry Prohibition Act and the dowry death of his wife. He was later acquitted of the dowry-related charges by a trial court in Rudrapur, but was convicted for abetment of his wife's suicide and sentenced to five years' rigorous imprisonment. Earlier, the high court granted him bail and stayed the execution of the sentence during the pendency of the appeal. Subsequently, Yadav filed an appeal seeking a stay on the conviction, arguing that it was necessary for him to continue his vital work in vaccine development. Based on several legal precedents concerning the suspension of conviction and execution of sentence, the court ordered a stay on the execution of both until the final disposal of the appeal. For the last three years, Yadav has served as senior manager at Indian Immunologicals Ltd., a leading vaccine manufacturer, where he is directly involved in vaccine R&D.
The Hindu
04-08-2025
- The Hindu
Uttarakhand High Court stays scientist's conviction in abetment of suicide case in ‘larger public interest'
The Uttarakhand High Court has stayed the conviction and five-year rigorous imprisonment of a vaccine scientist who was found guilty of abetting his wife's suicide. Granting relief to the scientist, Akash Yadav, who has done PhD in biotechnology from IIT Kharagpur, the single Bench of Justice Ravindra Maithani said suspending his conviction was in the larger public interest. The court observed that the convict was a scientist actively engaged in vaccine research and development and due to his conviction, he was unable to perform his duties. It also said that the scientist's research holds critical value for the society at large. Mr. Yadav was booked under the Dowry Prohibition Act and the dowry death of his wife. He was later acquitted of the dowry-related charges by a trial court in Rudrapur but was convicted for abetment of his wife's suicide and sentenced to five years' rigorous imprisonment. Earlier, the High Court granted him bail and stayed the execution of the sentence during the pendency of the appeal. Subsequently, Mr. Yadav filed an appeal seeking a stay on the conviction, arguing that it was necessary for him to continue his vital work in vaccine development. Based on several legal precedents concerning the suspension of conviction and execution of sentence, the court ordered a stay on the execution of both until the final disposal of the appeal. For the last three years, Mr. Yadav has served as senior manager at Indian Immunologicals Ltd., a leading vaccine manufacturer, where he is directly involved in vaccine R&D. (Those in distress or having suicidal thoughts are encouraged to seek help and counselling by calling the helpline numbers here)
Mint
04-07-2025
- Mint
AIIMS says no link between covid jabs and sudden deaths among young adults
Doctors at Delhi's All India Institute of Medical Sciences (AIIMS-Delhi) have refuted claims linking Covid-19 vaccines to sudden deaths in young adults in the country. This comes in the backdrop of recent claims by Karnataka Chief Minister Siddaramaiah stating that covid vaccines were linked to sudden deaths due to cardiac arrest among young adults in the state's Hassan district. The country's premier medical institution announced that its studies have found no such connection, instead attributing these tragic incidents primarily to lifestyle factors such as smoking, high blood pressure, and stress. Senior AIIMS doctors emphasized the crucial role these vaccines played in saving lives during the pandemic, noting that the studies are ongoing to determine the causes of sudden unexplained deaths. Researchers at AIIMS's pathology department are currently undertaking genomic studies to find the unexplained causes of death in approximately 25% of cases involving young individuals, where no apparent cause was initially identified. The pharmaceutical industry has also vouched for vaccine safety and debunked doubts over efficacy. Dr. Abhishek Yadav, additional professor in the department of forensic medicine at AIIMS, detailed two studies conducted by his department. A retrospective analysis from 2018 to 2022, comparing pre- and post-Covid data, found "no surge in the sudden cardiac deaths in the cases which were reported in the department". A second, ongoing study, initiated in 2023 in collaboration with the Indian Council of Medical Research (ICMR) and slated to continue for another year and a half, aims to gather more samples for scientifically validated results. This study has so far examined approximately 230 death cases, collecting family history, performing genomic and DNA level studies, and utilizing virtual autopsies. Dr. Yadav stated that this second study has also 'not found any link between covid vaccine and sudden deaths.' The research categorized cases into two age groups: 18-45 years and 45-65 years. Dr. Yadav said that coronary artery disease was identified as the most common historical factor, with over 50% of these cases linked to lifestyle factors and substance abuse, such as alcohol and smoking. The pathology department of AIIMS is continuing genomic studies on the remaining 25% of unexplained cases. Dr. Sudheer Arava, a professor in the department of pathology at AIIMS, explained that the study of 230 young individuals brought to the forensic department found heart attack to be the most common cause of death (50%), often linked to lifestyle risk indicators like high blood pressure, cholesterol, stress, and obesity. 'In 25% of cases, no identifiable cause of death was determined, and researchers are exploring potential molecular alterations. An interim report submitted to the ICMR indicates that nearly 50% of the deaths studied were due to heart attacks, with further research ongoing.' Dr. Sanjay Rai, professor at the department of community medicine at AIIMS, stated that the Covishield vaccine (developed by Oxford–AstraZeneca) showed an efficacy of 62.1%. He highlighted that various regulatory authorities have approved 37 different Covid-19 vaccines, with the World Health Organization (WHO) approving approximately 12, utilizing diverse technologies. For instance, Bharat Biotech's Covaxin uses a traditional technology, while Covishield and Russian Sputnik V are based on an adenovirus vector. Globally, over 13 billion vaccine doses have been administered, with countries like the United States completing fourth doses. The WHO now recommends vaccination for everyone aged six months and above, particularly with vaccines effective against newer variants. Dr. Karan Madan, associate professor in the department of pulmonary medicine, affirmed that Covid-19 vaccines were "highly effective and instrumental in lowering mortality rates during the pandemic". He emphasized their role as the "sole possible measure to save lives" at the time, providing "immense advantages" in preventing excess deaths. Dr. Madan also referenced a study on sudden cardiac deaths that found "no clear association" with vaccine usage. Sudarshan Jain, secretary general of the Indian Pharmaceutical Alliance (IPA), underscored India's role as a knowledge-driven sector, accounting for 60% of global vaccine production. He stated that Covid vaccines were "well documented and rigorously tested as per regulatory processes," warning that "misinformation and distortion of facts endanger public health and undermine the trust built on science and patient care globally". The Indian Vaccine Manufacturers Association also said that all Covid-19 vaccines in India received Emergency Use Authorization based on extensive preclinical and human clinical trial evaluations, showing positive results for safety, efficacy, and immunogenicity. Covid infections have been on a declining trend after showing a steady increase in the past few weeks. On Thursday, the country's active caseload dropped to 1,290 from 1,691 cases, with no deaths reported in the last 24 hours. The total number of Covid-19-related deaths this year stands at 146. The current spread is linked to Omicron sub-variants NB.1.8.1 and LF.7.
